Skip to main content
Erschienen in: International Cancer Conference Journal 1/2016

01.01.2016 | Case report

An extremely rare salivary gland tumor: intraductal carcinoma of the buccal mucosa

verfasst von: Junya Nojima, Mitsuhiko Nakahira, Hiroshi Yamaguchi, Shoichiro Kokabu, Tetsuya Yoda, Masashi Sugasawa

Erschienen in: International Cancer Conference Journal | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Intraductal carcinoma of the salivary gland is a rare, indolent neoplasm characterized by intraductal malignant cell proliferation but lacking invasiveness, in contrast to conventional salivary duct carcinoma, a clinically aggressive neoplasm with invasive characteristics. The tumor affects the major salivary glands much more frequently than the minor salivary glands. This report describes an extremely rare intraductal carcinoma arising from the buccal mucosa in a 61-year-old man who presented with a painless mass in the left buccal mucosa, which he had had for 1 month. A biopsy of the tumor indicated it was most likely an adenocarcinoma, but accurate preoperative diagnosis was difficult. The tumor was completely removed, along with sufficient margins. Histological examination revealed that the lesion was composed of proliferating epithelial cells surrounded by an intact myoepithelial layer, with no evidence of invasion. The final diagnosis was intraductal carcinoma of the salivary gland. No recurrence has been observed for over 3 years. In conclusion, the difficulty in preoperatively diagnosing this rare entity suggests that complete surgical excision with sufficient margins remains the best treatment option.
Literatur
1.
Zurück zum Zitat Kuo YJ, Weinreb I, Perez-Ordonez B (2013) Low-Grade salivary duct carcinoma or low-grade intraductal carcinoma? Head Neck Pathol 7:59–67PubMedCentralCrossRef Kuo YJ, Weinreb I, Perez-Ordonez B (2013) Low-Grade salivary duct carcinoma or low-grade intraductal carcinoma? Head Neck Pathol 7:59–67PubMedCentralCrossRef
2.
Zurück zum Zitat Chen KT (1983) Intraductal carcinoma of the minor salivary gland. J Laryngol Otol 97:189–191CrossRefPubMed Chen KT (1983) Intraductal carcinoma of the minor salivary gland. J Laryngol Otol 97:189–191CrossRefPubMed
3.
4.
Zurück zum Zitat Delgado R, Klimstra D, Albores-Saavedra J (1996) Low grade salivary duct carcinoma: a distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer 78:958–967CrossRefPubMed Delgado R, Klimstra D, Albores-Saavedra J (1996) Low grade salivary duct carcinoma: a distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer 78:958–967CrossRefPubMed
5.
Zurück zum Zitat Cheuk W, Miliauskas JR, Chan JK (2004) Intraductal carcinoma of the oral cavity: a case report and a reappraisal of the concept of pure ductal carcinoma in situ in salivary duct carcinoma. Am J Surg Pathol 28:266–270CrossRefPubMed Cheuk W, Miliauskas JR, Chan JK (2004) Intraductal carcinoma of the oral cavity: a case report and a reappraisal of the concept of pure ductal carcinoma in situ in salivary duct carcinoma. Am J Surg Pathol 28:266–270CrossRefPubMed
7.
Zurück zum Zitat Khurana KK, Pitman MB, Powers CN et al (1997) Diagnostic pitfalls of aspiration cytology of salivary duct carcinoma. Cancer 81:373–378CrossRefPubMed Khurana KK, Pitman MB, Powers CN et al (1997) Diagnostic pitfalls of aspiration cytology of salivary duct carcinoma. Cancer 81:373–378CrossRefPubMed
8.
Zurück zum Zitat Tatemoto Y, Ohno A, Osaki T (1996) Low malignant intraductal carcinoma on the hard palate: a variant of salivary duct carcinoma? Eur J Cancer B Oral Oncol 32:275–277CrossRef Tatemoto Y, Ohno A, Osaki T (1996) Low malignant intraductal carcinoma on the hard palate: a variant of salivary duct carcinoma? Eur J Cancer B Oral Oncol 32:275–277CrossRef
9.
Zurück zum Zitat Watatani K, Shirasuna K, Aikawa T et al (1991) Intraductal carcinoma of the tongue: report of a case. Int J Oral Maxillofac Surg 20:175–176CrossRefPubMed Watatani K, Shirasuna K, Aikawa T et al (1991) Intraductal carcinoma of the tongue: report of a case. Int J Oral Maxillofac Surg 20:175–176CrossRefPubMed
10.
Zurück zum Zitat Anderson C, Muller R, Piorkowski R et al (1992) Intraductal carcinoma of major salivary gland. Cancer 69:609–614CrossRefPubMed Anderson C, Muller R, Piorkowski R et al (1992) Intraductal carcinoma of major salivary gland. Cancer 69:609–614CrossRefPubMed
11.
Zurück zum Zitat Delgado R, Klimstra D, Albores-Saavedra J (1996) Low grade salivary duct carcinoma: a distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer 78:958–967CrossRefPubMed Delgado R, Klimstra D, Albores-Saavedra J (1996) Low grade salivary duct carcinoma: a distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer 78:958–967CrossRefPubMed
12.
Zurück zum Zitat Brandwein-Gensler M, Hille J, Wang BY et al (2004) Low-grade salivary duct carcinoma: description of 16 cases. Am J Surg Pathol 28(8):1040–1044CrossRefPubMed Brandwein-Gensler M, Hille J, Wang BY et al (2004) Low-grade salivary duct carcinoma: description of 16 cases. Am J Surg Pathol 28(8):1040–1044CrossRefPubMed
13.
Zurück zum Zitat Simpson RH (2013) Salivary duct carcinoma: new developments—morphological variants including pure in situ high grade lesions; proposed molecular classification. Head Neck Pathol 7:48–58PubMedCentralCrossRef Simpson RH (2013) Salivary duct carcinoma: new developments—morphological variants including pure in situ high grade lesions; proposed molecular classification. Head Neck Pathol 7:48–58PubMedCentralCrossRef
14.
Zurück zum Zitat Michal M, Skalova A, Simpson RH et al (1999) Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology 35:495–501CrossRefPubMed Michal M, Skalova A, Simpson RH et al (1999) Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology 35:495–501CrossRefPubMed
15.
Zurück zum Zitat Wenig BM (2008) Atlas of head and neck pathology. In: Major and minor salivary glands, 2nd edn. Elsevier Health Sciences, pp 664–665 Wenig BM (2008) Atlas of head and neck pathology. In: Major and minor salivary glands, 2nd edn. Elsevier Health Sciences, pp 664–665
16.
Zurück zum Zitat Hellquist H, Skalova A (2014) Other Carcinomas. Springer-Verlag, Berlin Heidelberg, Heidelberg, Histopathology of the salivary gland, pp 392–422 Hellquist H, Skalova A (2014) Other Carcinomas. Springer-Verlag, Berlin Heidelberg, Heidelberg, Histopathology of the salivary gland, pp 392–422
17.
Zurück zum Zitat Silverstein MJ, Rosser RJ, Gierson ED et al (1987) Axillary lymph node dissection for intraductal carcinoma: Is it indicated? Cancer 59:1819–1824CrossRefPubMed Silverstein MJ, Rosser RJ, Gierson ED et al (1987) Axillary lymph node dissection for intraductal carcinoma: Is it indicated? Cancer 59:1819–1824CrossRefPubMed
18.
Zurück zum Zitat Simpson RH, Desai S, Di Palma S (2008) Salivary duct carcinoma in situ of the parotid gland. Histopathology 53(4):416–425CrossRefPubMed Simpson RH, Desai S, Di Palma S (2008) Salivary duct carcinoma in situ of the parotid gland. Histopathology 53(4):416–425CrossRefPubMed
Metadaten
Titel
An extremely rare salivary gland tumor: intraductal carcinoma of the buccal mucosa
verfasst von
Junya Nojima
Mitsuhiko Nakahira
Hiroshi Yamaguchi
Shoichiro Kokabu
Tetsuya Yoda
Masashi Sugasawa
Publikationsdatum
01.01.2016
Verlag
Springer Japan
Erschienen in
International Cancer Conference Journal / Ausgabe 1/2016
Elektronische ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-015-0225-7

Weitere Artikel der Ausgabe 1/2016

International Cancer Conference Journal 1/2016 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.